These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 16227036

  • 1. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 2. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 3. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 4. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A.
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [Abstract] [Full Text] [Related]

  • 5. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G.
    J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
    [Abstract] [Full Text] [Related]

  • 6. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW.
    Ann Clin Lab Sci; 2008 Oct; 38(3):235-40. PubMed ID: 18715851
    [Abstract] [Full Text] [Related]

  • 7. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 8. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 9. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R.
    Pediatr Res; 2004 Nov 17; 56(5):701-5. PubMed ID: 15371568
    [Abstract] [Full Text] [Related]

  • 10. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun 17; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 11. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P, Camilot M, Teofoli F, Tatò L.
    Horm Res; 2005 Jun 17; 63(4):180-6. PubMed ID: 15818055
    [Abstract] [Full Text] [Related]

  • 12. Newborn screening for congenital adrenal hyperplasia in Wisconsin.
    Allen DB.
    Wis Med J; 1993 Feb 17; 92(2):75-8. PubMed ID: 8451862
    [Abstract] [Full Text] [Related]

  • 13. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY, Yee JK, Hicks RA, Mao CS, Lee WN.
    J Perinatol; 2017 Mar 17; 37(3):283-287. PubMed ID: 27929529
    [Abstract] [Full Text] [Related]

  • 14. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Mar 17; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 15. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan 17; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 16. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.
    Eur J Endocrinol; 2009 Aug 17; 161(2):285-92. PubMed ID: 19451212
    [Abstract] [Full Text] [Related]

  • 17. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S, Dean H, Dent W, Stockl E, Cronin C.
    Pediatrics; 1996 Jan 17; 97(1):100-2. PubMed ID: 8545200
    [Abstract] [Full Text] [Related]

  • 18. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.
    Brosnan CA, Brosnan P, Therrell BL, Slater CH, Swint JM, Annegers JF, Riley WJ.
    Public Health Rep; 1998 Jan 17; 113(2):170-8. PubMed ID: 9719819
    [Abstract] [Full Text] [Related]

  • 19. [Screening for congenital adrenal hyperplasia in Hungary].
    Sólyom J.
    Orv Hetil; 1989 Sep 10; 130(37):1979-82, 1985-6. PubMed ID: 2780047
    [Abstract] [Full Text] [Related]

  • 20. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M, Dauerer E, DiRienzo AG, Caggana M, Tavakoli NP.
    Eur J Pediatr; 2017 Jan 10; 176(1):121-129. PubMed ID: 27900477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.